首页 | 本学科首页   官方微博 | 高级检索  
检索        

双百抗痨合剂治疗耐多药结核病32例
引用本文:丁毅,刘贵超,齐嵘.双百抗痨合剂治疗耐多药结核病32例[J].中国中医药现代远程教育,2012,10(15):34-35.
作者姓名:丁毅  刘贵超  齐嵘
作者单位:1. 河南新乡医学院第一附属医院,新乡,453100
2. 河南南阳市骨科医院,南阳,473000
3. 河南平顶山市结核病防治所,平顶山,467000
摘    要:目的 观察双百抗痨合剂对耐药性结核病患者的临床疗效.方法 将符合条件的62例耐药性肺结核患者分成2组,进行治疗前后疗效的对比观察.结果 治疗组中痰菌阴转率为90.5%,病灶吸收好转率87.5%,其疗效均显著优于对照组.结论 在耐多药结合病治疗中伍用双百抗痨合剂,疗效显著优于单纯应用西药治疗,值得临床推广应用.

关 键 词:双百抗痨合剂  耐多药结核  中药

Two-hundred Anti-tuberculosis Mixture Treatment of 32 Cases of MDR-TB
Ding Yi , Liu Guichao , Qi Rong.Two-hundred Anti-tuberculosis Mixture Treatment of 32 Cases of MDR-TB[J].Chinese Medicine Modern Distance Education of China,2012,10(15):34-35.
Authors:Ding Yi  Liu Guichao  Qi Rong
Institution:1 The Frist Teaching Hospital Of Xinxiang Medical College,Weihui 453100,China;2 Orthopaedic Hospital of Nanyang City,Nanning 473000,China;3 The Pingdingshan TB Prophylactico-therapeutic hospital,Pingdingshan 467000,China)
Abstract:Objective Observation of two-hundred anti-tuberculosis drug-resistant TB patients mixture on the clinical efficacy.Methods 62 cases of drug-resistant tuberculosis patients were divided into two groups before and after the treatment efficacy of Observation.Results In the treatment group,sputum conversion rate was 90.5%,focus absorption rate of 87.5%,its efficacy was significantly better than the control group.Conclusion Multi-drug resistant disease in the combined treatment of Wu keeps the effect of significantly better than western medicine treatment,worthy of clinical application.
Keywords:Two-hundred anti-TB mixture  MDR-TB  TCM
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号